Patent details
EP2406629 Title: IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS
Basic Information
- Publication number:
- EP2406629
- PCT Application Number:
- PCT/US/2010/027244
- Type:
- European Patent Granted for LU
- Legal Status:
- Revoked
- Application number:
- EP107093601
- PCT Publication Number:
- WO/2010/105236
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS
- French Title of Invention:
- DOSAGES IMMUNOLOGIQUES DE L'ACTIVITÉ DES ENDOPEPTIDASES RECIBLÉES
- German Title of Invention:
- IMMUNBASIERTE TESTVERFAHREN FÜR ENDOPEPTIDASE-AKTIVITÄT MIT NEUEM ZIEL
- SPC Number:
Dates
- Filing date:
- 12/03/2010
- Grant date:
- 18/09/2013
- EP Publication Date:
- 18/09/2013
- PCT Publication Date:
- 16/09/2010
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 18/01/2012
- EP B1 Publication Date:
- 18/09/2013
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 12/03/2014
- Expiration date:
- 12/03/2030
- Renunciation date:
- Revocation date:
- 17/09/2020
- Annulment date:
Owner
- From:
- 12/03/2010
- Name:
- Allergan Inc.
- Address:
- 2525 Dupont Drive, Irvine, CA 92612, United States (US)
Inventor
1
- Name:
- WANG Joanne
- Address:
- United States (US)
2
- Name:
- HODGES D., Diane
- Address:
- United States (US)
3
- Name:
- FERNANDEZ-SALAS Ester
- Address:
- United States (US)
4
- Name:
- ZHU Hong
- Address:
- United States (US)
Priority
- Priority Number:
- 160217 P
- Priority Date:
- 13/03/2009
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- G01N 33/50;
Publication
European Patent Bulletin
- Issue number:
- 202110
- Publication date:
- 10/03/2021
- Description:
- Revocation of the European patent
| Filing date | Document type | Number of pages |
|---|